Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.075
Bid: 2.95
Ask: 3.20
Change: 0.20 (6.96%)
Spread: 0.25 (8.475%)
Open: 2.875
High: 3.075
Low: 2.875
Prev. Close: 2.875
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth

Fri, 20th Nov 2020 14:51

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

----------

Land Securities Group PLC - London-based commercial property developer - Chief Executive Officer Mark Allan buys 45,695 shares at GBP6.82, worth GBP311,772, on Thursday. Landsec last week reported a wider interim loss and a fall in net asset value but reinstated its dividend.

----------

SSE PLC - electricity utility based in Perth, Scotland - Colin Nicol, outgoing managing director of electricity distribution business, SSEN Distribution, sells 18,212 shares at GBP14.11, worth GBP256,990, on Wednesday.

----------

RSA Insurance Group PLC - London-based general insurance - Chief Legal Officer Charlotte Heiss sells 29,968 shares at GBP6.75, worth GBP202,344, on Thursday. RSA on Wednesday said it has reached an agreement to be sold and split up in a deal with a two-headed consortium which values the former Royal & Sun Alliance Insurance Group at GBP7.2 billion.

----------

Spirent Communications PLC - Crawley, England-based provider of testing, analytics and security for telecommunications networks - Dean Ritchie, associate of Chief Financial Officer Paula Bell, buys 50,000 shares at GBP2.57, worth GBP128,740, on Thursday. Bell now interested in 363,884 shares.

----------

Jardine Matheson Holdings Ltd - Hong Kong-headquartered holding company with interests in retail, property, hotels and motor dealerships - Ruby Weatherall, associate of Director Percy Weatherall, sells 3,100 shares at USD51.35, worth USD159,193, in Singapore on Thursday.

----------

H&T Group PLC - Surrey, England-based pawnbroker - CFO Richard Withers buys 10,000 shares for 227.4 pence, worth GBP22,740, on Wednesday.

----------

Allergy Therapeutics PLC - Sussex-based biotechnology firm focused on allergy vaccines - Non-Executive Chair Peter Jensen buys 100,000 shares at 14p, worth GBP14,000, on Thursday.

----------

easyJet PLC - Luton Airport-based budget airline - Non-Executive Director Nicholas Leeder buys 1,346 shares mostly at GBP7.53, worth GBP10,140, on Thursday.

----------

Henderson High Income Trust PLC - investment trust aiming for high-income stream and prospects of capital growth - Director Jeremy Rigg buys 10,000 shares at GBP1.46, worth GBP14,605, on Friday.

----------

Dunedin Enterprise Investment Trust PLC - invests in UK mid-market companies - Directors sell shares as part of company's tender offer at GBP3.85 on November 12. Brian and Fionnlagh Finlayson sell 27,572 shares. Duncan, Rosemary and Victoria Budge sell 12,449 shares. Angela and David Lane sell 4,307. Company bought back 2.5 million shares in total, spending about GBP9.8 million.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
30 Nov 2015 09:25

Allergy Therapeutics Completes Patient Enrolment For Birch Study

Read more
17 Nov 2015 14:36

Allergy Therapeutics raises £12m to develop peanut and dust mite treatments

(ShareCast News) - Shares in Allergy Therapeutics fell as, despite a strong trading update, the company launched a £12m discounted fundraising to speed development of treatments for peanut allergy and house dust mites allergies. The AIM-listed company completes the institutional placing by mid-after

Read more
17 Nov 2015 13:03

UPDATE: Allergy Therapeutics Raises GBP11.5 Million To Fund Growth (ALLISS)

Read more
17 Nov 2015 10:14

Allergy Therapeutics To Raise GBP12 Million To Fund Growth (ALLISS)

Read more
16 Nov 2015 16:37

AGM, EGM Calendar - Week Ahead

Read more
4 Nov 2015 10:43

Allergy Therapeutics To Present Adjuvant Data At Spain Conference

Read more
13 Oct 2015 08:43

BROKER RATINGS SUMMARY: Citi Cuts AB Foods As UBS Raises Smiths Group

Read more
21 Sep 2015 08:11

Allergy Therapeutics Says Outlook "Very Positive" As Profit Falls

Read more
14 Sep 2015 14:58

Earnings, Trading Statements Calendar - Week Ahead

Read more
1 Sep 2015 08:35

Allergy Therapeutics Enrols First Patient For Birch Drug Study

Read more
10 Aug 2015 07:23

Allergy Therapeutics Says Paper Published In World Allergy Journal

Read more
27 Jul 2015 16:58

Allergy Technologies' chief executive buys 50,000 shares

(ShareCast News) - The chief executive of Allergy Therapeutics bought new shares in the company few days after releasing a positive trading update. Manuel Llobet purchased 50,000 shares for an individual price of 24.45p, spending a total of £12,225. After the transaction, Llobet holds 3.175m shares

Read more
27 Jul 2015 16:24

DIRECTOR DEALINGS SUMMARY: New MySale Chairman Buys 60,000 Shares

Read more
27 Jul 2015 11:37

DIRECTOR DEALINGS: Allergy Therapeutics CEO Buys 50,000 Shares

Read more
23 Jul 2015 08:38

Allergy Therapeutics Expects Revenue Growth Despite Euro Weakness

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.